Lindbrook Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,190 shares of AUPH stock, worth $11,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,190

Previous 1,190 -0.0%

Holding current value

$11,364

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$4.81 - $5.78 $5,723 - $6,878	1,190 New	1,190 $6,000
Q4 2023 Jan 31, 2024	SELL	$7.13 - $9.49 $577 - $768	-81 Reduced 18.79%	350 $3,000
Q3 2023 Oct 25, 2023	BUY	$7.77 - $12.27 $1,313 - $2,073	169 Added 64.5%	431 $3,000
Q1 2023 Apr 26, 2023	SELL	$5.94 - $11.27 $29 - $56	-5 Reduced 1.87%	262 $2,000
Q4 2022 Jan 24, 2023	BUY	$4.11 - $8.14 $1,097 - $2,173	267 New	267 $0
Q3 2021 Nov 05, 2021	SELL	$10.93 - $23.55 $43,720 - $94,200	-4,000 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$10.0 - $14.52 $10,000 - $14,520	1,000 Added 33.33%	4,000 $52,000
Q1 2021 Apr 28, 2021	SELL	$12.3 - $18.73 $12,300 - $18,730	-1,000 Reduced 25.0%	3,000 $39,000
Q4 2020 Jan 27, 2021	BUY	$12.94 - $16.05 $51,760 - $64,200	4,000 New	4,000 $55,000
Q3 2020 Nov 03, 2020	SELL	$13.19 - $16.66 $19,785 - $24,990	-1,500 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$14.12 - $18.33 $21,180 - $27,494	1,500 New	1,500 $24,000
Q1 2020 Apr 22, 2020	SELL	$11.34 - $21.46 $39,690 - $75,110	-3,500 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$3.88 - $21.42 $7,760 - $42,840	2,000 Added 133.33%	3,500 $71,000
Q3 2019 Oct 31, 2019	SELL	$5.34 - $6.59 $26,700 - $32,950	-5,000 Reduced 76.92%	1,500 $8,000
Q2 2019 Jul 24, 2019	BUY	$6.05 - $6.75 $3,025 - $3,375	500 Added 8.33%	6,500 $42,000
Q1 2019 Apr 23, 2019	BUY	$6.06 - $7.64 $24,240 - $30,560	4,000 Added 200.0%	6,000 $39,000
Q4 2018 Feb 07, 2019	BUY	$5.08 - $6.83 $10,160 - $13,660	2,000 New	2,000 $13,000

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.36B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History